Xeomin 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FNSWL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,969
Award facts
- Contract value 100% obligated
- $13,968.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,968.50 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 unit vials. This firm fixed-price contract was competitively awarded without set-aside designation and carries an ultimate completion date of May 23, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems.
Xeomin is a botulinum toxin product used in medical and therapeutic applications. As a major pharmaceutical distributor registered in the System for Award Management, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill federal procurement requirements across multiple therapeutic domains through open competition, with delivery orders ranging significantly in value. This award reflects AmerisourceBergen's role as a key vendor within the DLA's global pharmaceutical support framework for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FNSWL?
SPE2DB25FNSWL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FNSWL worth?
The government has obligated $13,969 on SPE2DB25FNSWL.
Is contract SPE2DB25FNSWL an order under another contract?
Yes. SPE2DB25FNSWL is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNSWL competed?
The extent of competition for SPE2DB25FNSWL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award